H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. [electronic resource]
- PLoS pathogens Sep 2012
- e1002914 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1553-7374
10.1371/journal.ppat.1002914 doi
Adamantane--pharmacology Amino Acid Substitution Antiviral Agents--pharmacology Binding Sites--genetics Crystallography, X-Ray Drug Resistance, Viral--genetics Enzyme Inhibitors--pharmacology Humans Hydrophobic and Hydrophilic Interactions Influenza A Virus, H1N1 Subtype--drug effects Influenza, Human--drug therapy Mutation Neuraminidase--antagonists & inhibitors Oseltamivir--pharmacology Pandemics Protein Conformation Zanamivir--pharmacology